Carboxypeptidase B structure
|
Common Name | Carboxypeptidase B | ||
|---|---|---|---|---|
| CAS Number | 9025-24-5 | Molecular Weight | 610.721 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 966.7±65.0 °C at 760 mmHg | |
| Molecular Formula | C31H38N4O7S | Melting Point | N/A | |
| MSDS | USA | Flash Point | 538.4±34.3 °C | |
| Symbol |
GHS07, GHS08 |
Signal Word | Danger | |
Use of Carboxypeptidase BCarboxypeptidase B is a peptide exonuclease that can specifically degrade peptide chains. Carboxypeptidase B is progressively degraded from the C-terminal to release free amino acids. Carboxypeptidase B hydrolyzes only peptide bonds with basic amino acids (such as arginine and lysine) as C-terminal residues[1][2]. |
| Name | 4-[[1-[[1-[2-[(1-benzylsulfanyl-1-oxo-3-phenylpropan-2-yl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Carboxypeptidase B is a peptide exonuclease that can specifically degrade peptide chains. Carboxypeptidase B is progressively degraded from the C-terminal to release free amino acids. Carboxypeptidase B hydrolyzes only peptide bonds with basic amino acids (such as arginine and lysine) as C-terminal residues[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 966.7±65.0 °C at 760 mmHg |
| Molecular Formula | C31H38N4O7S |
| Molecular Weight | 610.721 |
| Flash Point | 538.4±34.3 °C |
| Exact Mass | 610.246094 |
| PSA | 197.75000 |
| LogP | 3.26 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.595 |
| Storage condition | −20°C |
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H315-H319-H334-H335 |
| Precautionary Statements | P261-P305 + P351 + P338-P342 + P311 |
| Personal Protective Equipment | Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 36 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Effects of citraconylation on enzymatic modification of human proinsulin using trypsin and carboxypeptidase B.
Biotechnol. Prog. 25(4) , 1064-70, (2009) Insulin is a polypeptide hormone which is produced by the beta-cell of pancreas and controls the blood glucose level in the human body. Enzymatic modification of human proinsulin using trypsin and car... |
|
|
Comparative study on activation mechanism of carboxypeptidase A1, A2 and B: First insights from steered molecular dynamics simulations
J. Mol. Graph. Model. 38 , 298-303, (2012) Graphical abstract |
|
|
Structural basis for inhibition of carboxypeptidase B by selenium-containing inhibitor: selenium coordinates to zinc in enzyme.
J. Med. Chem. 56(19) , 7527-35, (2013) Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) is a zinc-containing carboxypeptidase and significantly inhibits fibrinolysis. TAFIa inhibitors are thus expected to act as profibrinolyti... |
| Protaminase |
| N-(3-Carboxypropanoyl)alanylalanyl-N-[1-(benzylsulfanyl)-1-oxo-3-phenyl-2-propanyl]prolinamide |
| Peptidyl-L-lysine(L-arginine) hydrolase |
| Carboxypeptidase B from human pancreas |
| Protaminase,AEBSF treated |
| Prolinamide, N-(3-carboxy-1-oxopropyl)alanylalanyl-N-[2-oxo-1-(phenylmethyl)-2-[(phenylmethyl)thio]ethyl]- |
| Carboxypeptidase B from porcine pancreas |